Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 5, 2012 18 Pages - SKU: ICDR6793200 |
| Synopsis ICD Research's Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Apotex, Inc.. ICD Research's Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Apotex Inc. (Apotex) is one of the leading generic drugmakers in Canada. The company engages in the research, development, manufacture and distribution of generic drugs in Canada and internationally. The company produces around 300 generic drugs in more than 4,000 dosages and formats. It also develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, disposable plastics, packaging components, and medical devices for medical use. Through agreement and subsidiaries, Apotex exports to more than 115 countries across Turkey, Belgium, Australia, Czech Republic, Netherlands, Mexico, Poland, New Zealand, and the UK. The company is headquartered in Toronto, Canada. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

